Abiopharma

SLBとVår Energi、坑井計画と統合型フィールド開発計画の規模拡大に向けデジタル協業を拡大

SLB與Vår Energi擴大數位化合作，規模化推進油井與綜合油田開發規劃

IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer

Peabody Prices $225 Million Convertible Senior Notes Offering

SOLV Energy Announces Pricing of Upsized Public Offering of Class A Common Stock

AVAV Investors Have Opportunity to Lead AeroVironment, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Brera Holdings Issues Letter to Shareholders

INVESTOR ALERT: Securities Class Action Filed Against AeroVironment, Inc. – Investors Encouraged to Contact Kirby McInerney LLP

Chagee Announces First Quarter 2026 Unaudited Financial Results

Nakamoto Chairman and CEO David Bailey Purchases Additional Shares of Common Stock